Indeed, miR-338-3p mimics inhibited EYA2 expression in ZR75-1, MCF-7 and MDA-MB-231 human breast cancer cells and 4T1 mouse cancer cells (Figure 3a; Supplementary Figure S3A). Here, EYA2 is linked to breast carcinoma.